Astera Labs (NASDAQ:ALAB) Director Manuel Alba Sells 183,000 Shares

Key Points

• Manuel Alba, a director at Astera Labs, sold 183,000 shares on September 2nd for $31.7 million, reducing his ownership by 32.17% to 385,863 shares.
• Astera Labs' stock price surged $11.34 on Thursday, reaching $187.95, with a market cap of $31.24 billion and a price-to-earnings ratio of 333.23.
• The company reported a quarterly EPS of $0.44, beating estimates, and projected Q3 2025 EPS guidance between $0.380 - $0.390.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Manuel Alba sold 183,000 shares of the business's stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Manuel Alba also recently made the following trade(s):

• On Monday, July 21st, Manuel Alba sold 13,259 shares of Astera Labs stock. The shares were sold at an average price of $111.00, for a total transaction of $1,471,749.00.
• On Thursday, July 3rd, Manuel Alba sold 30,991 shares of Astera Labs stock. The shares were sold at an average price of $91.13, for a total transaction of $2,824,209.83.
• On Wednesday, July 2nd, Manuel Alba sold 63,000 shares of Astera Labs stock. The shares were sold at an average price of $89.95, for a total transaction of $5,666,850.00.
• On Friday, June 20th, Manuel Alba sold 20,150 shares of Astera Labs stock. The shares were sold at an average price of $100.84, for a total transaction of $2,031,926.00.

Astera Labs Stock Performance

ALAB stock traded up $11.34 during trading on Thursday, hitting $187.95. The stock had a trading volume of 7,048,580 shares, compared to its average volume of 4,623,106. The company's 50 day moving average price is $137.83 and its two-hundred day moving average price is $97.51. Astera Labs, Inc. has a 1-year low of $36.85 and a 1-year high of $199.47. The stock has a market cap of $31.24 billion, a price-to-earnings ratio of 333.23, a price-to-earnings-growth ratio of 4.48 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company's quarterly revenue was up 149.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently bought and sold shares of ALAB. Oliver Lagore Vanvalin Investment Group purchased a new position in Astera Labs in the 2nd quarter worth about $29,000. Bernard Wealth Management Corp. purchased a new position in Astera Labs in the 2nd quarter worth about $36,000. Clearstead Trust LLC increased its stake in Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company's stock worth $42,000 after purchasing an additional 461 shares in the last quarter. Advisors Asset Management Inc. increased its stake in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after purchasing an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC grew its stake in Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company's stock valued at $44,000 after acquiring an additional 283 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ALAB shares. William Blair started coverage on Astera Labs in a research note on Thursday, May 22nd. They set an "outperform" rating on the stock. Evercore ISI raised their price objective on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Roth Capital set a $100.00 target price on Astera Labs and gave the company a "buy" rating in a research note on Wednesday, May 7th. Barclays reiterated an "overweight" rating and issued a $155.00 target price (up from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Finally, Jefferies Financial Group raised their target price on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $142.00.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.